PubMed Health⌕ Search

PubMed · 15893121

Does clozapine work by blocking spikes and sparing bursts?

Abstract

Clozapine works better and produces fewer side effects than other antipsychotics. Existing hypotheses fail to explain why. A new hypothesis, single spike suppression, supposes that psychotic symptoms are mediated by the single spikes of neurons at the D2 receptor. All antipsychotics block these spikes. Clozapine, according to the hypothesis, blocks these spikes but, unlike other antipsychotics, spares the spike bursts that mediate movement, cognition and affect. This study explores the mathematical feasibility of single spike suppression. Could an antipsychotic with the right receptor kinetics selectively block single spikes? Could this selectivity have clinical consequences? To develop the hypothesis, the author made a mathematical model of the receptor occupancy of a synapse, and performed five simulations, varying input data within the range established by research. The effects of hypothetical antipsychotics on single spikes and bursts were compared. The author confirmed that a drug with the right dissociation rate constant (k off) would dissociate slowly enough to block single spikes, but rapidly enough to spare longer bursts. If the hypothesis is correct, this spike-selective, burst-sparing drug would work at relatively low D2 occupancies, and cause minimal D2-related side effects. Single spike suppression may explain the superior properties of clozapine better than competing hypotheses. If so, it would provide a better model for a new generation of safe, effective antipsychotics.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Timothy P Olson. 2005. Does clozapine work by blocking spikes and sparing bursts?. https://doi.org/10.1016/j.mehy.2005.01.035

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Differential pharmacology of atypical antipsychotics: clinical implications.

PURPOSE: Pharmacology of atypical antipsychotics and the clinical implications are reviewed. SUMMARY: Psychiatric disorders, such as schizophrenia and bipolar disorder, are often associated with poor outcomes. Atypical antipsychotics have become the standard of care for these disorders, and multiple agents have demonstrated efficacy for both acute and maintenance therapy. As a result of their differential pharmacologic properties, atypical antipsychotics have diverse clinical profiles, resulting in different liabilities for specific adverse events. These effects can, in turn, have an adverse impact on patient functionality, adherence to therapy, and overall health. CONCLUSION: Atypical antipsychotics have distinct pharmacological profiles which result in clinically meaningful differences in adverse effects. Clinicians should have a wide choice of agents available with which to optimize outcomes in the majority of patients with psychiatric disorders.

Antipsychotic Agents↗